Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jovita Crasta

Psychiatry Baldwin, NY Medical Doctor

NPI 1053302711 CMS profile 2723

2277 Grand Ave, Baldwin, NY 11510

Open in the dashboard

General payments

$618,708

578 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jovita Crasta of Baldwin, NY is reported in the CMS Open Payments database as having received $618,708 across 578 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $150,238 126
2024 General $120,646 105
2023 General $109,704 88
2022 General $105,460 91
2021 General $65,330 62
2020 General $27,571 36
2019 General $39,758 70

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jovita Crasta
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Jovita Crasta were reported at $150,238. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Jovita Crasta Psychiatry median Middle half National median
2019 $39,758 $184 $59–$605 $163
2020 $27,571 $119 $36–$372 $114
2021 $65,330 $143 $43–$576 $132
2022 $105,460 $153 $50–$590 $149
2023 $109,704 $170 $56–$651 $160
2024 $120,646 $179 $57–$673 $164
2025 $150,238 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Neurocrine Biosciences, Inc. $572,708 492 payments
  2. E.R. Squibb & Sons, L.L.C. $38,404 43 payments
  3. Sunovion Pharmaceuticals Inc. $5,554 8 payments
  4. Otsuka America Pharmaceutical, Inc. $669 9 payments
  5. Janssen Pharmaceuticals, Inc $344 4 payments
  6. Alkermes, Inc. $300 5 payments
  7. AbbVie, Inc. $153 2 payments
  8. ITI, Inc. $139 2 payments
  9. Indivior Inc. $113 1 payment
  10. Teva Pharmaceuticals USA, Inc. $89 4 payments
  11. Other $234 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $489,047 163 payments
  2. Consulting Fee $75,836 18 payments
  3. Travel and Lodging $35,134 144 payments
  4. Food and Beverage $18,691 253 payments
Products named General payments · program years 2019–2025
  1. INGREZZA Neuropsychiatry $446,867 357 payments
  2. INGREZZA Neurology $61,963 52 payments
  3. INGREZZA Neurology $58,388 80 payments
  4. COBENFY $10,151 20 payments
  5. LATUDA $5,554 8 payments
  6. ABILIFY MAINTENA $391 4 payments
  7. SPRAVATO $344 4 payments
  8. REXULTI $303 6 payments
  9. ARISTADA INITIO $180 4 payments
  10. ARISTADA $180 4 payments
  11. Other $2,138 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

578 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record